Savara, Inc. · NASDAQ:SVRA
Frazier Life Sciences Public Fund, L.P.'s stake in Savara, Inc. fell to 4.10% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Frazier Life Sciences Public Fund, L.P.'s stake in Savara, Inc. fell to 4.10%, 8,343,048 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 8,343,048
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 11 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 4.10% | 8,343,048 |
| FHMLSP, L.P. | 4.10% | 8,343,048 |
| FHMLSP, L.L.C. | 4.10% | 8,343,048 |
| Frazier Life Sciences X, L.P. | 0.10% | 279,365 |
| FHMLS X, L.P. | 0.10% | 279,365 |
| FHMLS X, L.L.C. | 0.10% | 279,365 |
| Frazier Life Sciences XI, L.P. | 0.60% | 1,239,888 |
| FHMLS XI, L.P. | 0.60% | 1,239,888 |
| FHMLS XI, L.L.C. | 0.60% | 1,239,888 |
| James N. Topper | 0.10% | 279,365 |
| Patrick J. Heron | 0.10% | 279,365 |
Source
Related
- Savara, Inc.
- Frazier Life Sciences Public Fund, L.P.
- Savara, Inc. shareholders
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2025
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · May 15, 2025
- Form 4 · Parker Braden C. · Sep 25, 2026
- Schedule 13G/A · Farallon Capital Management, L.L.C. · Aug 14, 2026
- Form 4 · Lutz Robert Matthew · Jul 24, 2026
- Form 4 · Lowrance David L · Jun 22, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Feb 17, 2026